Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:APSNYSEARCA:COMCVE:IBTNYSEARCA:SCYB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPSAptose BiosciencesC$3.55+26.8%C$6.14C$1.98▼C$62.40C$152.86M1.363,058 shs10,898 shsCOMDirexion Auspice Broad Commodity Strategy ETF$28.76-2.3%$29.01$28.16▼$30.40$243.02M0.0755,120 shs89,849 shsIBTIBEX TechnologiesC$1.44C$1.44C$0.75▼C$1.45C$35.54M-0.0568,888 shs200 shsSCYBSchwab High Yield Bond ETF$25.76-1.1%$26.30$25.36▼$26.79$947.97M0.33302,153 shs442,342 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPSAptose Biosciences+26.79%-34.62%-6.82%-65.20%-94.05%COMDirexion Auspice Broad Commodity Strategy ETF-2.31%-1.74%+0.21%+1.41%-1.27%IBTIBEX Technologies0.00%0.00%0.00%0.00%0.00%SCYBSchwab High Yield Bond ETF-1.11%-1.30%-2.16%-1.90%-0.08%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPSAptose BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AN/AN/AN/AN/AN/AIBTIBEX TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ASCYBSchwab High Yield Bond ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPSAptose Biosciences 4.00Strong BuyN/AN/ACOMDirexion Auspice Broad Commodity Strategy ETF 0.00N/AN/AN/AIBTIBEX Technologies 0.00N/AN/AN/ASCYBSchwab High Yield Bond ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IBT, APS, SCYB, and COM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/27/2025APSAptose BiosciencesAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 4/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPSAptose BiosciencesN/AN/AC$2.22 per share1.60C($0.92) per shareN/ACOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AN/AN/AN/AIBTIBEX TechnologiesC$5.77M6.15C$0.92 per share1.56C$0.58 per share2.48SCYBSchwab High Yield Bond ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPSAptose Biosciences-C$154.69M-C$5.02N/A∞N/AN/A1,017.48%-136.29%N/ACOMDirexion Auspice Broad Commodity Strategy ETFN/AN/A0.00∞N/AN/AN/AN/AN/AIBTIBEX TechnologiesC$3.10MC$0.1211.52∞N/A53.78%21.95%6.42%N/ASCYBSchwab High Yield Bond ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPSAptose BiosciencesN/A0.39%N/AN/AN/ACOMDirexion Auspice Broad Commodity Strategy ETF$1.073.72%N/AN/AN/AIBTIBEX TechnologiesN/A3.11%N/AN/AN/ASCYBSchwab High Yield Bond ETF$1.887.30%N/AN/AN/ALatest IBT, APS, SCYB, and COM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date1/15/2025COMDirexion Auspice Broad Commodity Strategy ETF$0.25433/25/20253/25/20254/1/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPSAptose Biosciences-117.371.055.41COMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AIBTIBEX Technologies11.066.244.93SCYBSchwab High Yield Bond ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPSAptose Biosciences15.10%COMDirexion Auspice Broad Commodity Strategy ETFN/AIBTIBEX Technologies19.05%SCYBSchwab High Yield Bond ETFN/AInsider OwnershipCompanyInsider OwnershipAPSAptose Biosciences17.11%COMDirexion Auspice Broad Commodity Strategy ETFN/AIBTIBEX Technologies25.36%SCYBSchwab High Yield Bond ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPSAptose Biosciences3143.06 millionN/ANot OptionableCOMDirexion Auspice Broad Commodity Strategy ETFN/A8.25 millionN/ANot OptionableIBTIBEX TechnologiesN/A24.68 millionN/ANot OptionableSCYBSchwab High Yield Bond ETFN/A36.80 millionN/ANot OptionableIBT, APS, SCYB, and COM HeadlinesRecent News About These CompaniesSchwab High Yield Bond ETF (SCYB) Dividend HistoryMarch 29, 2025 | nasdaq.comTrend Tracker for (SCYB)February 11, 2025 | news.stocktradersdaily.com(SCYB) Trading SignalsJanuary 31, 2025 | news.stocktradersdaily.comThese High-Yield Dividend Stocks Are Looking Better Than Bonds for SafetyJanuary 27, 2025 | msn.comWhen the Price of (SCYB) Talks, People ListenJanuary 20, 2025 | news.stocktradersdaily.com(SCYB) Investment ReportDecember 30, 2024 | news.stocktradersdaily.comWhen (SCYB) Moves Investors should ListenDecember 19, 2024 | news.stocktradersdaily.comSchwab High Yield Bond ETF declares monthly distribution of $0.1489December 3, 2024 | msn.com(SCYB) Proactive StrategiesNovember 18, 2024 | news.stocktradersdaily.comSchwab High Yield Bond ETF declares monthly distribution of $0.1667November 5, 2024 | msn.com(SCYB) Long Term Investment AnalysisOctober 17, 2024 | news.stocktradersdaily.comWhere are the Opportunities in (SCYB)September 15, 2024 | news.stocktradersdaily.comSchwab High Yield Bond ETF declares monthly distribution of $0.3075September 4, 2024 | msn.comSCHO: A Low-Risk, High-Yield Pick To Boost Your Dividend Portfolio's StabilityAugust 29, 2024 | seekingalpha.comTrading (SCYB) With Integrated Risk ControlsAugust 19, 2024 | news.stocktradersdaily.comHigh Yield Bond ETFs Have New Asset LeaderAugust 16, 2024 | etftrends.com(SCYB) Trading AdviceAugust 8, 2024 | news.stocktradersdaily.comSchwab High Yield Bond ETF declares monthly distribution of $0.3195August 2, 2024 | msn.comSchwab Municipal Bond ETF declares monthly distribution of $0.1481May 2, 2024 | msn.comSchwab High Yield Bond ETF declares monthly distribution of $0.322May 2, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockThese 3 Iconic Brands Just Announced Bigger Dividend PayoutsBy Leo Miller | March 7, 2025View These 3 Iconic Brands Just Announced Bigger Dividend PayoutsEli Lilly Pours $27B Into U.S. Growth—What It Means for InvestorsBy Leo Miller | March 6, 2025View Eli Lilly Pours $27B Into U.S. Growth—What It Means for InvestorsQuantum Gamble? Is IonQ's Stock an Opportunity or a Mirage?By Jeffrey Neal Johnson | March 25, 2025View Quantum Gamble? Is IonQ's Stock an Opportunity or a Mirage?Small-Caps, Big Buybacks: 3 Stocks With Large Buyback CapacityBy Leo Miller | March 25, 2025View Small-Caps, Big Buybacks: 3 Stocks With Large Buyback CapacityIBT, APS, SCYB, and COM Company DescriptionsAptose Biosciences TSE:APSC$3.55 +0.75 (+26.79%) As of 04/3/2025 03:57 PM EasternAptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.Direxion Auspice Broad Commodity Strategy ETF NYSEARCA:COM$28.76 -0.68 (-2.31%) As of 04/3/2025 04:10 PM EasternThe Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.IBEX Technologies CVE:IBTC$1.44 0.00 (0.00%) As of 04/5/2024IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Schwab High Yield Bond ETF NYSEARCA:SCYB$25.76 -0.29 (-1.11%) Closing price 04/3/2025 04:10 PM EasternExtended Trading$25.88 +0.12 (+0.45%) As of 04/3/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Schwab High Yield Bond ETF (SCYB) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks an index of USD-denominated high-yield, US corporate bonds, selected and weighted based on market value. SCYB was launched on Jul 11, 2023 and is managed by Charles Schwab. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum 5 Reasons Why Halliburton Is a Good Buy in 2025 First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock Tesla Stock: What To Expect With Their Delivery Numbers Report Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future Equinix: A Smart Bet on Data Centers, Dividends, and AI Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
